| H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| POU5F1P3 |
|
POU class 5 homeobox 1 pseudogene 3
|
|
|
0.452 |
0.808 |
| POU5F1P4 |
|
POU class 5 homeobox 1 pseudogene 4
|
|
|
0.452 |
0.808 |
| CXADRP1 |
|
CXADR pseudogene 1
|
|
|
0.463 |
0.846 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| MIR10B |
|
microRNA 10b
|
|
|
0.509 |
0.808 |
| MIR100 |
|
microRNA 100
|
|
|
0.521 |
0.846 |
| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| CD177 |
Q8N6Q3
|
CD177 molecule
|
|
|
0.595 |
0.654 |
| ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
| USP17L2 |
Q6R6M4
|
ubiquitin specific peptidase 17 like family member 2
|
|
|
0.686 |
0.385 |
| USP17L9P |
|
ubiquitin specific peptidase 17 like family member 9, pseudogene
|
|
|
0.722 |
0.308 |
| USP17L24 |
Q0WX57
|
ubiquitin specific peptidase 17 like family member 24
|
|
|
0.751 |
0.269 |
| USP17L25 |
Q0WX57
|
ubiquitin specific peptidase 17 like family member 25
|
|
|
0.751 |
0.269 |
| USP17L26 |
Q0WX57
|
ubiquitin specific peptidase 17 like family member 26
|
|
|
0.751 |
0.269 |
| USP17L27 |
Q0WX57
|
ubiquitin specific peptidase 17 like family member 27
|
|
|
0.751 |
0.269 |
| USP17L28 |
Q0WX57
|
ubiquitin specific peptidase 17 like family member 28
|
|
|
0.751 |
0.269 |
| USP17L29 |
Q0WX57
|
ubiquitin specific peptidase 17 like family member 29
|
|
|
0.751 |
0.269 |
| USP17L30 |
Q0WX57
|
ubiquitin specific peptidase 17 like family member 30
|
|
|
0.751 |
0.269 |
| IFNA8 |
P32881
|
interferon alpha 8
|
|
|
0.839 |
0.115 |
| ROS1 |
P08922
|
ROS proto-oncogene 1, receptor tyrosine kinase
|
Kinase
|
1.6E-72 |
0.439 |
0.885 |
| SPG7 |
Q9UQ90
|
SPG7 matrix AAA peptidase subunit, paraplegin
|
Enzyme
|
2.0E-36 |
0.436 |
0.885 |
| NOC2L |
Q9Y3T9
|
NOC2 like nucleolar associated transcriptional repressor
|
|
2.9E-29 |
0.593 |
0.731 |